Literature DB >> 1453351

[Teratogenic action of alpha-asarone in the mouse].

M Salazar1, S Salazar, V Ulloa, T Mendoza, N Pages, G Chamoro.   

Abstract

The embryotoxicity and teratogenicity of alpha-asarone were investigated in mice. The drug was dissolved in corn oil, and administered daily, by gavage, on days 6 to 15 of gestation, at 0 (controls), 5, 15, 30 and 60 mg/kg. Fetuses were removed on day 18 by caesarean section and examined using routine teratological methods. A significant maternal toxicity was observed in dams given 60 mg/kg, as indicated by a reduced weight gain. An embryolethality was observed in 15, 30 and 60 mg/kg treated groups. In addition, the highest dose induced fetal malformations, mainly represented by hydrocephaly, extra-ribs, clubfeet and cleft lips.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1453351

Source DB:  PubMed          Journal:  J Toxicol Clin Exp        ISSN: 0753-2830


  2 in total

1.  Metabolism of carcinogenic alpha-asarone by human cytochrome P450 enzymes.

Authors:  Alexander T Cartus; Dieter Schrenk
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-09-05       Impact factor: 3.000

2.  Revealing the Antiepileptic Effect of α-Asaronol on Pentylenetetrazole-Induced Seizure Rats Using NMR-Based Metabolomics.

Authors:  Xue Zhao; Lihong Liang; Ru Xu; Peixuan Cheng; Pu Jia; Yajun Bai; Yajun Zhang; Xinfeng Zhao; Xiaohui Zheng; Chaoni Xiao
Journal:  ACS Omega       Date:  2022-02-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.